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ABSTRACT
P21, a cyclin-dependent kinase inhibitor, plays a
pivotal role in the cell-cycle regulation in response
to stress stimuli. P21 expression is highly regulated
through transcriptional, post-transcriptional and
post-translational mechanisms. Previously, we and
others showed that p21 expression is regulated
through p21 mRNA stability by RNPC1, a target of
the p53 family and HuR, a member of the ELAV
family RNA-binding proteins. HuR carries three
highly conserved RNA recognition motifs (RRMs)
whereas RNPC1 carries one. Here we found that
the ability of RNPC1 to regulate p21 mRNA stability
is dependent on HuR. We also found that RNPC1 and
HuR physically interact, and the RRM domain in
RNPC1 and RRM3 in HuR are necessary for their
interaction. Interestingly, we found that RNPC1 and
HuR,bothofwhichcanbindAU-richelements(AREs)
in p21 30-UTR, preferentially bind the upstream and
downstream AREs, respectively. Finally, we showed
thattheRNA-binding activity ofHuRtop21transcript
was enhanced by RNPC1 in vitro and in vivo.
Together, we hypothesize that RNPC1 modulates
the RNA-binding activity of, and cooperates with,
HuR to regulate p21 mRNA stability.
INTRODUCTION
P21, a cyclin-dependent kinases (CDKs) inhibitor, is a
major mediator of p53 to regulate the cell-cycle transition
from G1 to S and G2 to M (1–3). In addition, upon
exposure to certain stress signals, p21 is highly induced,
leading to irreversible growth arrest in the early stages of
cellular senescence and diﬀerentiation (4–5). Thus, p21
expression is highly regulated in response to stress
signals, through transcriptional, post-transcriptional and
post-translational mechanisms (6). For example, p21
expression is upregulated by many transcription factors,
including the p53 family (7,8). P21 expression is also
regulated by protein turnover via multiple
post-translational modiﬁcations, such as ubiquitination
and phosphorylation (5,9). Furthermore, p21 expression
is regulated by mRNA turnover (5). The rate of mRNA
turnover is controlled by speciﬁc elements, such as
AU-rich elements (AREs), which are usually located in
the 30-UTR and recognized by various RNA-binding
proteins. Indeed, p21 mRNA stability is found to be
regulated by a group of RNA-binding proteins that have
an aﬃnity to poly(C) and a family of RNA-binding
proteins that contain RNA recognition motif (RRM)
and have an aﬃnity to AREs (5,10).
The Hu/ELAV family of RNA-binding proteins
consists of HuB, HuC, HuD and HuR, all of which
carry several RRMs and are known to bind the
ARE-containing transcripts, including p21 transcript
(11). HuB, HuC and HuD are expressed in terminally
diﬀerentiated neurons and neuroendocrine tumors
whereas HuR is ubiquitously expressed (12–19). Recent
studies showed that upon UV irradiation, HuR is
phosphorylated by p38 MAPK and PKC and translocated
from nucleus to cytosol wherein p21 mRNA stability is
regulated by HuR (9,20–26). RNPC1, also called RBM38,
is a RNA-binding protein with one RRM domain and a
target of the p53 family (27). RNPC1 is expressed as two
isoforms, RNPC1a with 239 amino acids and RNPC1b
with 121 amino acids (27). RNPC1 is also found to
regulate p21 mRNA stability by binding to p21 30-UTR
(27). Thus, both HuR and RNPC1 bind to p21 30-UTR
and regulate p21 expression. Although a variety of
RNA-binding proteins are known to regulate p21
mRNA stability via binding to p21 transcript, it is still
unclear how these RNA-binding proteins cooperatively
or antagonistically regulate p21 expression. Here we
showed that HuR is necessary for RNPC1 to regulate
p21 mRNA stability. In addition, we found that RNPC1
directly interacts with HuR and enhances its
RNA-binding activity to p21 30-UTR. These data
suggest that RNPC1 cooperates with HuR to regulate
p21 expression.
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Plasmids
To generate glutathione S-transferase (GST)- and
histidine (His)-tagged RNPC1a, the coding region of
RNPC1a was ampliﬁed by PCR and cloned into
pGEX4T3, pRSet-A and pcDNA3.1/HisB vectors, respec-
tively. To generate GST-, His- and Myc-tagged HuR, the
coding region of HuR was ampliﬁed by PCR and cloned
into pGEX4T3, pRSet-A, pcDNA3.1/HisB and pcDNA3/
Myc, respectively. To generate constructs expressing
HA-tagged RNPC1a lacking RNP1 or RNP2, two-step
PCR reactions were performed. The ﬁrst-step was per-
formed to separately amplify two cDNA fragments.
Fragment #1 was ampliﬁed with forward primer,
50-GAA GCT T GC CGC CAT GGA GTA CCC ATA
CGA CGT ACC AGA TTA CGC TAT GCT GCT GCA
GCC CGC GCC G-30 and reverse primer, 50-GGC GTC
GGT AGT GTG GTA CTT GGT GAA CGT GGT GTC
C-30 for RNPC1a(RNP1), or 50-AGC TGC CGC CCG
GTC GGC GGA CTT GCC CGT CTG GCG GT-30 for
RNPC1a(RNP2). Fragment #2 was ampliﬁed with
forward primer, 50-GGA CAC CAC GTT CAC CAA
GTA CCA CAC TAC CGA CGC C-30 for
RNPC1a(RNP1), or 50-ACC GCC AGA CGG GCA
AGT CCG CCG ACC GGG CGG CAG CT-30 for
RNPC1a(RNP2) and reverse primer, 50-GGA ATT
CTC ACT GCA TCC TGT CAG GCT GC-30. The
second-step PCR reaction was performed using a
mixture of fragments #1 and #2 as a template with the
forward primer for fragment #1 and the reverse primer for
fragment #2, and resulting fragments were separately
cloned and conﬁrmed by sequencing. A HindIII–EcoRI
fragment containing the coding region for RNP1 and
RNP2 was puriﬁed and cloned into pcDNA4.
Cell culture and siRNA transfection
RKO and MCF7 cell lines that inducibly express
HA-tagged RNPC1a, RNPC1b, RNP1 and RNP2
were generated and cultured as previously reported (27).
For siRNA knockdown, cells were transfected with
scrambled siRNA or siRNA against HuR (50-GGGATA
AAGTAGCAGGACA-30) using siLentFect
TM Lipid
Reagent (Bio-Rad) and harvested for analysis 48h later.
Western blot analysis and immunoprecipitation
Cells were harvested by scrapping and extracted with
2 SDS/sample buﬀer. Proteins were separated in 8% or
12% SDS–PAGE, transferred to a nitrocellulose
membrane and probed with indicated antibodies
followed by ECL detection. The antibodies used in this
study were: anti-HuR (H-280, Santa Cruz), anti-p53
(DO-1 and Pab1801; Santa Cruz), anti-p21 (C-19,
H-164; Santa Cruz), anti-actin (Sigma), anti-Omni probe
(for His-tag recognition: D-8, Santa Cruz), anti-HA
(HA.11, Covance) and anti-Myc (9E10, Cell signaling).
For immunoprecipitation, cell lysates were pre-treated
with RNase A (0.5mg/ml) and then incubated with
1mg of antibody and protein A/G beads for 4h.
The immuncomplexes were washed and used for western
blot analysis.
Quantitative RT–PCR (qRT–PCR)
Total RNAs were puriﬁed with a Trizol reagent
(Invitrogen). Reverse transcription was performed with
iScript (Bio-Rad). PCR reaction was performed using
Absolute Blue SyBr Green QPCR Master mix (Thermo)
and realplex2 Mastercycler (Eppendorf). The primers used
to amplify RNPC1 were forward primer 50-ACGCCTCG
CTCAGGAAGTA-30 and reverse primer, 50-GTCTTTG
CAAGCCCTCTCAG-30. The primers used to amplify
HuR were forward primer 50-CGCAGAGATTCAGGT
TCTCC-30 and reverse primer, 50-GCCCCAGGTTGTA
GATGAAA-30. The primers used to amplify p21 and
GAPDH were as described (27).
RNA-immunoprecipitation (RNA–IP)
RNA-IP was carried out as described (27). Brieﬂy, cells
were seeded at 5 10
6 per 100mm plate and uninduced or
induced to express RNPC1a for 24h. Cell extracts were
prepared with lysis buﬀer (10mM HEPES, pH 7.0,
100mM KCl, 5mM MgCl2, 0.5% NP-40, 1mM DTT)
and then incubated with 2mg of anti-HA, anti-HuR, or
mouse IgG at 4 C for 4h. The RNA-protein
immunocomplexes were brought down by protein A/G
beads, and RNA was then puriﬁed from the complexes
for RT–PCR.
GST-pull down assay
Recombinant GST- and His-tagged RNPC1, HuR and
their mutants were expressed in Escherichia coli BL21
(DE3) and puriﬁed by standard protocol (28). Ten
picomoles of His-tagged RNPC1 (or HuR) and
GST-fused HuR (or RNPC1) were mixed and incubated
in a binding buﬀer (50mM HEPES, pH 7.6, 50mM NaCl,
5mM EDTA, 0.1% NP-40 and glycerol) at 4 C for 2h,
followed by precipitation with glutathione-sepharose
4B beads. Beads were washed three times and resuspended
in 1 SDS loading buﬀer. The interaction of HuR–
RNPC1 was detected by western blot analysis.
RNA Electrophoretic Mobility Shift Assay (REMSA)
Various regions in p21 30-UTR were PCR-ampliﬁed using
primers containing T7 promoter sequence (50-GGATCCT
AATACGACTCACTATAGGGAG-30). RNA probes
were made from in vitro transcription by T7 RNA
polymerase in the presence of a-
32P-UTP. REMSA was
performed with 200nM of recombinant protein, 1mg/ml
of yeast tRNA and 50000 CPM
32P-labeled RNA probe in
a reaction buﬀer (10mM Tris–Cl, pH 7.5, 25mM KCl,
5mM MgCl2, 1mM DTT) for 20min at 25 C. RNA/
protein complexes were digested with 100U RNaseT1
for 10min at 37 C and then separated in 7% of native
PAGE. RNA-protein complexes were visualized by
autoradiography. For supershift assay, 3mg of anti-HA
antibody was pre-incubated with HA-tagged proteins for
30min on ice prior to incubation with a RNA probe.
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Cells were washed with ice-cold PBS for three times and
harvested by scrapping. To isolate cytoplasmic fractions,
cells were resuspended in lysis buﬀer for immunopre-
cipitaiton (20mM Tris–Cl, pH 8.0, 125mM NaCl, 2mM
EDTA, 0.5% NP-40, protease inhibitor cocktail) and
pelleted by centrifugation (5000rpm, 5min, 4 C).
Supernatants were saved and used as cytoplasmic
fraction. To prepare nuclear fractions, pellets (nuclei)
were washed two times with the lysis buﬀer without
NP-40, re-suspended in the lysis buﬀer and sonicated for
20s. Cell debris from nuclear extracts was removed by
centrifugation.
RESULTS
HuR is necessary for RNPC1 to regulate p21
mRNA stability
Recently, we and others showed that RNPC1 and HuR,
both of which share a homology in their RNA-binding
motifs, are capable of enhancing p21 mRNA stability
via directly binding p21 30-UTR (27,29). As a critical reg-
ulator of the cell cycle, p21 expression needs to be tightly
controlled. Interestingly, RNPC1 can be induced by DNA
damage in a p53-dependent manner (27), whereas HuR is
ubiquitously expressed. Thus, we examined whether HuR
is required for RNPC1 to regulate p21. To test this, the
level of p21 was measured in RKO cells, which were
transfected with scrambled siRNA or siRNA against
HuR and then uninduced or induced to express
HA-tagged RNPC1a for 2days. We showed that upon
induction of RNPC1a, the level of p21 protein was
markedly increased (Figure 1A, compare lanes 1–2), con-
sistent with previous report (27). We also showed that the
level of HuR protein was decreased by siRNA against
HuR but not scrambled siRNA (Figure 1A, compare
lanes 1–2 with 3–4). Interestingly, upon knockdown of
HuR, the extent of p21 induction by RNPC1a was
signiﬁcantly diminished (Figure 1A, compare lanes 1
and 3 with 2 and 4, respectively). Since the increased
expression of p21 by RNPC1 is due to enhanced p21
mRNA stability (27), the level of p21 transcript along
with HuR and RNPC1 was measured by qRT–PCR. We
showed that the level of HuR transcript was decreased by
 80% by siRNA against HuR compared to that by
scrambled siRNA regardless of RNPC1 overexpression
(Figure 1B, HuR column). In addition, we found that
upon inducible expression of RNPC1, the level of
RNPC1 transcript was increased by  5- to 6-fold
(Figure 1B, RNPC1 column). We would like to mention
that endogenous RNPC1 can be increased by more than
3-fold in response to DNA damage or p53 activation
(27,30), suggesting that the level of RNPC1 expressed in
the inducible RNPC1-producing RKO cells is within the
physiological range. Consistent with the above result, we
showed that the level of p21 transcript increased by
RNPC1 was signiﬁcantly diminished upon knockdown
of HuR (Figure 1B, p21 column). However, knockdown
of HuR alone had no obvious eﬀect (Figure 1B,
p21 column). Conversely, we examined whether over-
expression of HuR is capable of enhancing RNPC1-
mediated p21 induction. We showed that upon expression
of Myc-tagged HuR in RKO cells, the extent of
the increase in p21 protein by RNPC1 was enhanced
(Figure 1C, compare lanes 1 and 3 with 2 and 4, respec-
tively). In contrast, ectopic expression of HuR alone had
no obvious eﬀect on p21 expression (Figure 1C, compare
Figure 1. HuR is necessary for RNPC1 to regulate p21 expression.
(A) The level of p21, HuR, RNPC1a and actin was measured in RKO
cells transfected with scrambled siRNA (SCR) or siRNA against HuR for
24h, followed with or without induction of RNPC1a for 48h. (B) The
level of p21, RNPC1 and HuR transcripts was measured by qRT–PCR
with total RNA puriﬁed from RKO cells treated as in (A) above. The level
of GAPDH transcript was measured as an internal control for normal-
ization. *P<0.05 (Students’ t-test). (C) The level of p21, HuR,
Myc-HuR, RNPC1a and actin was measured in RKO cells transfected
with an empty vector or a vector expressing Myc-tagged HuR for 24h,
followed with or without induction of RNPC1a for 48h.
2258 Nucleic Acids Research, 2010,Vol.38, No. 7lane 1 with 3), consistent with the idea that HuR needs to
be activated in order to exert its eﬀect on p21 mRNA
stability (22).
RNPC1 physically interacts with HuR in vitro and in vivo
Considering that RRMs constitute a unique set of
protein–protein interaction motifs (31), we examined
whether HuR and RNPC1 physically interact and
whether their interaction plays a role in the regulation of
p21 mRNA stability. To test this, potential RNPC1–HuR
complexes were immunoprecipitated by either
anti-RNPC1 or anti-HuR, followed by western blot
analysis. To eliminate the possibility that RNPC1 inter-
acts with HuR indirectly via binding to the same RNA
transcript, all assays were performed with cell extracts
treated with RNase A to degrade RNAs prior to
immunoprecipitation. First, potential interaction
between RNPC1 and HuR was examined in MCF7 cell
line that can inducibly express HA-tagged RNPC1. We
showed that endogenous HuR was detected in RNPC1
but not control IgG immunocomplexes (Figure 2A,
compare lanes 2–3). Conversely, HA-tagged RNPC1 was
detected in HuR immunocomplexes (Figure 2A, compare
lanes 5–6). Next, the interaction between RNPC1 and
HuR was examined in RKO cells co-transfected with
HA-tagged RNPC1a and His-tagged HuR. We showed
that HuR was detected in RNPC1a immunocomplexes
(Figure 2B, lane 3) whereas RNPC1 was detected in
HuR immunocomplexes (Figure 2B, lane 6). To further
examine the physical interaction between RNPC1 and
Figure 2. RNPC1 physically interacts with HuR in vitro and in vivo.( A) MCF7 cells were induced to express HA-tagged RNPC1a for 16h, and then
used for immunoprecipitation with anti-HA (lane 3), anti-HuR (lane 6), or mouse IgG (lanes 2 and 5). The immunoprecipitated complexes were
analyzed by western blot analysis using anti-HA to detect HA-RNPC1a or anti-HuR to detect HuR. (B) RKO cells were transiently transfected with
HA-tagged RNPC1a and His-tagged HuR for 48h, and then used for immunoprecipitation with anti-HA to recognize HA-RNPC1 (lane 3),
anti-Omni to recognize His-HuR (lane 6) or mouse IgG (lanes 2 and 5). The immunoprecipitated complexes were analyzed by western blot
analysis using anti-HA to detect HA-RNPC1a or anti-Omni to detect His-HuR. (C) GST or GST-RNPC1a recombinant proteins were incubated
with His-tagged HuR in a pull-down buﬀer containing glutathione sepharose beads for 2h. Protein complexes on the beads were washed, and used
for western blot analysis with anti-GST to detect GST and GST-RNPC1a or anti-Omni to detect His-HuR. Input controls were presented in lanes
1–3. (D) The experiment was performed as in (C) except that HuR was GST-tagged whereas RNPC1a was His-tagged. (E) Whole-cell extracts from
RKO cells were used for immunoprecipitation with anti-HuR (lane 3), anti-RNPC1 (lane 4) or mouse IgG (lanes 2). The immunoprecipitated
complexes were analyzed by western blot analysis with anti-HuR or anti-RNPC1. (F) Cytoplasmic and nuclear extracts were puriﬁed from RKO cells
transiently transfected with HA-tagged RNPC1a and Myc-tagged HuR for 48h and then used for immunoprecipitation with anti-HA to recognize
HA-RNPC1 immunocomplexes (lane 4 and 6) or mouse IgG as a control (lanes 5 and 7). Whole cell lysates, cytoplasmic and nuclear extracts, and
anti-HA and mouse IgG immunocomplexes were analyzed by western blot analysis using anti-HuR, anti-Myc to detect Myc-HuR, anti-HA to detect
HA-RNPC1, anti-hnRNP C1/C2, anti-GAPDH and anti-clathrin heavy chain, respectively. (G) Cytoplasmic and nuclear extracts from RKO cells
were used for immunoprecipitation with anti-HuR (lanes 4 and 6) or mouse IgG (lanes 5 and 7). Whole cell lysate, cytoplasmic and nuclear extracts
and anti-HuR and mouse IgG immunocomplexes were analyzed by western blot analysis using anti-RNPC1, anti-HuR, anti-hnRNP C1/C2,
anti-GAPDH and anti-clathrin heavy chain, respectively.
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showed that His-tagged HuR bound to GST-RNPC1 but
not GST beads (Figure 2C, compare lanes 5–6).
Conversely, His-tagged RNPC1 bound to GST-HuR but
not GST beads (Figure 2D, compare lanes 5–6). To verify
the physical interaction between RNPC1 and HuR in vivo,
we examined the interaction of endogenous RNPC1a
with endogenous HuR in RKO cells. We showed
that endogenous RNPC1 was detected in HuR
immunocomplexes (Figure 2E, lane 3). Conversely,
endogenous HuR was also detected in RNPC1a
immunocomplexes (Figure 2E, lane 4). Together, our
data demonstrate that RNPC1 directly interacts with
HuR in vitro and in vivo.
Considering that the majority of HuR protein is
localized in nucleus and HuR can be translocated from
nucleus to cytoplasm upon exposure to a stress, we
examined in which cell compartment (i.e. nucleus and
cytoplasm) RNPC1 and HuR physically interact. First,
the level of HuR and RNPC1 was examined in
cytoplasmic and nuclear extracts puriﬁed from RKO
cells co-transfected with HA-tagged RNPC1a and
Myc-tagged HuR. We showed that the majority of
endogenous HuR protein was localized in nucleus
whereas a small amount in cytoplasm (Figure 2F, HuR
panel, lanes 1–3), consistent with previous report (29). In
addition, Myc-tagged HuR was similarly distributed in
cells as endogenous HuR (Figure 2F, Myc-HuR panel,
lanes 1–3). However, a majority of RNPC1a was localized
in cytoplasm (Figure 2F, RNPC1 panel, lanes 1–3), con-
sistent with previous report (27). As a control, GAPDH
and clathrin heavy chain were primarily localized in cyto-
plasm whereas hnRNP C1 and C2 were primarily
expressed in nucleus. Next, cytoplasmic and nuclear
extracts containing potential HuR-RNPC1 complexes
were used for immunoprecipitation by either
anti-RNPC1 or anti-HuR, followed by western blot
analysis. We showed that both endogenous and
Myc-tagged HuR were detected in
RNPC1a-immunocomplexes from either cytoplasmic or
nuclear extracts (Figure 2F, lanes 4 and 6). Conversely,
we showed that endogenous RNPC1a was detected in
endogenous HuR immunocomplexes from either
cytoplasmic or nuclear extracts (Figure 2G, lanes 4 and
6). These results indicate that RNPC1 interacts with HuR
regardless of cellular compartment.
Next, we wanted to examine whether RNPC1b, which
lacks most of the C-terminal region in RNPC1a, interacts
with HuR. To test this, the interaction between RNPC1b
and HuR was examined in RKO cells transfected with
HA–RNPC1b and His–HuR. We showed that like
RNPC1a (Figure 2), RNPC1b was detected in HuR
immunocomplexes (Figure 3B, lane 6). Conversely, we
showed that His-HuR protein was detected in
RNPC1b-immunocomplexes (Figure 3B, lane 3). To
examine the aﬃnity of HuR to RNPC1a and RNPC1b,
in vitro GST-pull down assay was performed. We showed
that His-tagged HuR had a much stronger aﬃnity to
GST-tagged RNPC1a than to GST-tagged RNPC1b
(Figure 3C, compare lanes 7–8). This suggests that the
N-terminal region in RNPC1 is suﬃcient for, but the
C-terminal region in RNPC1a facilitates, the interaction
Figure 2. Continued.
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RNPC1 consists of two sub-domains, RNP1 and RNP2
(27), we determined which sub-domain in RNPC1 is
required for its interaction with HuR. We found that
while RNPC1a was detected in HuR immunocomplexes,
RNP1 and RNP2 were not immunoprecipitated with
HuR (Figure 3D, compare lanes 8–10). This suggests that
both RNP1 and RNP2 sub-domains are required for the
interaction between RNPC1 and HuR.
Similarly, the domain in HuR necessary for interacting
with RNPC1 was determined. To test this, various HuR
deletion mutants were made as GST-fusion proteins for
GST pull down assay (Figure 4A). We found that
His-tagged RNPC1 bound to GST-HuR (1–326),
GST-HuR (134–326), GST-HuR (183–326) and weakly
to GST-HuR (245–326), but little if any to GST-HuR
(1–133) and GST (Figure 4B, lanes 9–14). Furthermore,
we showed that the binding aﬃnity of HuR (95-244) and
HuR (245–326) to RNPC1 was comparable (Figure 4C,
lanes 9–10). This suggests that RRM3 in HuR is suﬃcient
for, but the hinge region facilitates, the interaction
between HuR and RNPC1.
RNPC1 binds to AREs in p21 30-UTR and enhances the
RNA-binding activity of HuR in vitro and in vivo
Previously, we showed that RNPC1 directly binds to p21
30-UTR and regulates the stability of luciferase transcript
fused to the region between nt 571–727 (27). However, the
binding site in p21 30-UTR for RNPC1 was not mapped.
Thus, REMSA was performed with puriﬁed recombinant
RNPC1 and
32P-labeled RNA probes corresponding to
various regions in p21 30-UTR (Figure 5A). We showed
that RNPC1 bound strongly to A and A1 fragments,
weakly to A2 fragment, but not to B fragment (Figure
5B, lanes 2, 5, 8 and 11). The speciﬁcity of the RNPC1
binding to these fragments was veriﬁed by competition
assay using an excess amount of their own unlabeled
probes (Figure 5B, compare lanes 2, 5, 8 and 11 with
lanes 3, 6, 9 and 12, respectively). We also showed that
the binding of RNPC1 to probe A was inhibited by cold
probe A1 and A2 (Figure 5C, compare lane 2 with 3–4)
whereas the binding of RNPC1 to probe A1 was inhibited
by cold probe A2 (Figure 5C, compare lanes 6–7).
Conversely, the binding of RNPC1 to probe A2 was
inhibited by cold probe A1 (Figure 5C, compare lanes
9–10). In addition, we showed that HA-tagged RNPC1
in the RNPC1–RNA complexes were recognized and
supershifted by anti-HA (Figure 5D, compare lanes 2–
3). To further map the region in fragment A1, four
well-deﬁned RNA probes were generated (Figure 5A):
probe A11, which is derived from nt 621–740 and
contains two ARE elements and a poly(C)-rich element;
probe A11-ARE, which is a derivative of probe A11 but
lacks both ARE1 and ARE2 elements; and probes
A11-ARE1 and A11-ARE2, which lack ARE1 and
ARE2, respectively. We showed that RNPC1 bound to
A11, weakly to A11-ARE1 and A11-ARE2, but not
to A11-ARE (Figure 5E). This suggests that a transcript
containing one ARE can be recognized by RNPC1, but
Figure 3. RRM in RNPC1 is necessary for interacting with HuR.
(A) Schematic presentation of RNPC1a, RNPC1b, RNP1 and
RNP2. The location of RRM domain and RNP sub-domains are
indicated. (B) RKO cells were transfected with His-tagged HuR for
24h and then induced to express HA-tagged RNPC1b for another
24h. Potential HuR–RNPC1b complexes were immunoprecipitated
with anti-HA (lane 3), anti-Omni (lane 6) or mouse IgG (lanes 2 and
5), which were then used for western blot analysis using anti-HA to
detect HA-RNPC1b or anti-Omni to detect His-HuR. (C) GST,
GST-RNPC1a or GST-RNPC1b recombinant proteins was incubated
with His-tagged HuR in a pull-down buﬀer containing glutathione
sepharose beads for 2h. Protein complexes on the beads were
washed, and used for western blot analysis with anti-GST to detect
GST, GST-RNPC1a and GST-RNPC1b or anti-Omni to detect
His-HuR. Input controls were presented in lanes 1–4. (D) RKO cells
were transfected with His-tagged HuR along with HA-tagged RNPC1a,
RNP1, or RNP2 for 48h, and then used for immunoprecipitation
with anti-Omni. The immunoprecipitated His–HuR complexes were
analyzed by western blot analysis with anti-HA to detect HA-RNPC1
or anti-Omni to detect His–HuR. Input control was presented in
lanes 1–5.
Nucleic Acids Research,2010, Vol.38, No. 7 2261the aﬃnity of RNPC1 to a transcript with two AREs is
markedly increased.
Fragment A1 contains a region of poly(C), which can be
recognized by poly(C)-binding proteins, including PCBP1
(32). In addition, a region overlapping with the AREs in
fragment A2 was found to be recognized by HuR (11).
Thus, the binding of HuR and PCBP1 to fragments A1
and A2 was measured. We showed that HuR had a
stronger aﬃnity to the AREs in fragment A2 than that
in A1 (Figure 5F, compare lane 3 with 6). We also showed
that PCBP1 had a weak aﬃnity to fragment A1 but not to
fragment A2 (Figure 5F, lanes 2 and 5). This is not sur-
prising since fragment A2 does not contain a poly(C)-rich
element. These data indicate that RNPC1 and HuR have
their own preferential AREs in p21 30-UTR: RNPC1 to
the upstream AREs within nt 621–750 versus HuR to
downstream AREs within nt 751-850. Next, we
examined whether RNPC1 and HuR modulate each
other’s RNA-binding activity to p21 30-UTR. To test
this, the binding of HuR and RNPC1 to fragment A
Figure 4. RRM 3 in HuR is suﬃcient for interacting with RNPC1. (A) Schematic presentation of HuR and various deletion mutants. (B and C)
GST or various GST-HuR proteins were incubated with His-tagged RNPC1a in a pull-down buﬀer containing glutathione sepharose beads for 2h.
Protein complexes on the beads were washed and then used for western blot analysis with anti-GST to detect GST and various GST-tagged HuR
proteins or anti-Omni to detect His-tagged RNPC1. Input controls were presented in lanes 1–7 (B) and lanes 1–5 (C).
2262 Nucleic Acids Research, 2010,Vol.38, No. 7Figure 5. Identiﬁcation of AREs as a RNPC1-binding site in p21 30-UTR. (A) Schematic presentation of p21 30-UTR along with the location of
AREs, poly(C)-rich region, HuD-binding site and RNA probes used for REMSA. (B) REMSA was performed by mixing
32P-labeled probe A, A1,
A2, or B with recombinant GST or GST-HA-RNPC1a. An excess amount of unlabeled cold probe was used for competition in lanes 3, 6, 9 and 12.
(C) The experiment was performed as in (B) except probes used. For competition assay, an excess amount of unlabeled cold probe (A1 or A2) was
added to a reaction mixture containing RNPC1 and probe A, A1 or A2. (D) For supershift assay, 3mg of anti-HA antibody was added to a reaction
mixture containing probe A1 and GST-HA-RNPC1. (E) The experiment was performed as in (B) except probes used. (F) HuR has a higher aﬃnity
to probe A2 than A1 whereas PCBP1 only weakly binds to probe A1. The experiment was performed with GST-tagged HuR or PCBP1 mixed with
32P-labeled probe A1 or A2. (G and H) RNPC1 cooperates with HuR to bind p21 transcript. GST-tagged RNPC1a or RNPC1b was mixed with
GST-tagged HuR and
32P-labeled probe A for REMSA analysis. (I) RNPC1 inhibits the binding of HuD to p21 transcript. The experiment was
performed as in (G–H) except that GST-tagged HuD was used. (J and K) The experiments were performed as in (G) except the probes used.
Nucleic Acids Research,2010, Vol.38, No. 7 2263was examined. We showed that while RNPC1a and HuR
bound to fragment A, a combination of HuR and
RNPC1a markedly enhanced the RNA-binding aﬃnity
of HuR to fragment A (Figure 5G, lanes 2-4). In
addition, we showed that RNPC1b, which had a weak
interaction with HuR (Figure 3) and had a weak
RNA-binding activity to the AREs in fragment A, were
also capable of enhancing the RNA-binding activity of
HuR, albeit to a lesser extent (Figure 5H). Since AREs
in fragment A1 can be recognized by HuD (29), we
examined the eﬀect of RNPC1 on HuD binding to the
AREs in fragment A. We showed that while HuD had a
strong aﬃnity to the AREs in fragment A, its
RNA-binding activity was markedly decreased when
RNPC1 was present (Figure 5I, lanes 2–4), suggesting
that RNPC1 and HuD compete to recognize the same
AREs. Considering that RNPC1 has a stronger aﬃnity
to AREs in fragment A1 than in A2 whereas HuR has a
stronger aﬃnity to A2 than to A1, we examined whether
the binding of RNPC1 to RNA is necessary for enhancing
the RNA-binding activity of HuR. To test this, the
binding of HuR and RNPC1 to fragment A1 or A2 was
examined. We showed that a combination of HuR and
RNPC1a markedly enhanced the RNA-binding aﬃnity
of HuR to fragment A1 but not to fragment A2
(Figure 5J–K, lanes 3–4). This suggests that the
enhanced RNA-binding activity of HuR to p21 transcript
is dependent on the binding of RNPC1 to the same
transcript.
To examine whether RNPC1 is capable of enhancing
the RNA-binding activity of HuR in vivo, RNA
immunoprecipitation assay was performed with cell
extracts puriﬁed from RKO cells uninduced or induced
to express RNPC1 for 24h. We showed that p21 transcript
was detected in RNPC1a but not control IgG immunopre-
cipitates (Figure 6A, compare lanes 3–4). We also showed
that p21 transcript was detected in HuR immunopre-
cipitates (Figure 6A, lane 3), consistent with the fact
that HuR is ubiquitously expressed (22). Interestingly,
the level of p21 transcript associated with HuR was
markedly increased in the presence of RNPC1 (Figure
6A, HuR panel, compare lanes 3–4). To quantify the
level of p21 transcript associated with RNPC1 and
HuR, qRT–PCR was performed and showed that upon
expression of RNPC1a, the level of p21 transcript
associated with RNPC1 was increased by 5-fold (Figure
6B). Importantly, we found that the amount of p21 tran-
script associated with HuR was further increased by
 2-fold when RNPC1 was present (Figure 6B). To
further test this, RNA immunoprecipitation assay was
performed with cell extracts puriﬁed from MCF7 cells
uninduced or induced to knockdown RNPC1a for
3days. We showed that upon induction, the level of
RNPC1 transcript was markedly reduced (Figure 6C,
compare lanes 1–2), leading to marked decrease of p21
transcript (Figure 6D, input panel), consistent with
previous report (27). In addition, we showed that upon
knockdown of RNPC1a, the level of p21 transcript
associated with HuR was markedly reduced (Figure 6D,
HuR panel, compare lanes 3–4). These results suggest that
upon knockdown of RNPC1, the loss of HuR binding to
p21 mRNA is at least in part due to decreased
RNA-binding activity of HuR as well as decreased
amounts of p21 mRNA available for HuR to interact.
Together, our data indicate that the RNA-binding
activity of HuR can be enhanced by RNPC1 in vitro and
in vivo.
DISCUSSION
Here, we showed that knockdown of HuR inhibits the
extent of p21 mRNA stability induced by RNPC1. We
also provided evidence that RNPC1 directly interacts
with, and then enhances the RNA-binding activity of,
HuR. Furthermore, we showed that the ability of
RNPC1 to induce p21 expression is enhanced by ectopic
expression of HuR. This suggests that activation of HuR
by RNPC1 contributes to p21 expression. Considering
that HuR is capable of enhancing p53 translation in
response to UV irradiation (33), p53-RNPC1–HuR
forms a feedback–feedforward loop to coordinately
regulate p21 expression and thus the cell-cycle control
(Figure 7). Together, we hypothesize that in response to
stress signals, p53 is activated and induces RNPC1, which
modulates the RNA-binding activity of HuR, which in
Figure 5. Continued.
2264 Nucleic Acids Research, 2010,Vol.38, No. 7turn increases p53 expression via translation and cooper-
ates with RNPC1 to regulate p21 mRNA stability.
Previously, we showed that RNPC1 binds to p21
30-UTR (27), but it is not clear whether AREs are the
sequence to which RNPC1 binds. Within nt 621–750,
there are two AREs, designated upstream AREs, which
can be recognized by HuD (11). In addition, within nt
751–850, there are two additional AREs, designated
downstream AREs, which can be recognized by HuR
(29). Interestingly, we showed that RNPC1 has a much
higher aﬃnity to the upstream AREs than to the down-
stream AREs. Consistent with this, we showed that
RNPC1 competes with HuD to bind the upstream
AREs. In addition, we showed that RNPC1 promotes,
rather than competes with, HuR to bind the downstream
AREs and the binding of RNPC1 to RNA is required for
enhancing the RNA-binding activity of HuR. These data
suggest that although RRM has a propensity to bind an
ARE sequence (11,27,29), the RRM in RNPC1 has a
unique property that is similar to HuD, but diﬀerent
from HuR. Furthermore, it appears that while RNPC1
is able to recognize a transcript with one ARE, the
aﬃnity of RNPC1 to the one with two AREs is
markedly increased (Figure 5E). Considering that
RNPC1 has only one RRM (27) and both sub-domains
(RNP1 and RNP2) in RNPC1 RRM are essential for
RNA binding (data not shown), we postulate that
RNPC1 may exist as a dimer. Thus, when one RRM
from RNPC1 dimer binds to ARE, the binding of other
RRM from the dimer to ARE is stabilized. Similarly,
when RNPC1 and HuR form a heterodimer, the binding
of RNPC1 to one ARE element in A1 probe enhances the
binding of HuR to the other ARE element (Figure 5J).
However, due to weak or no binding of RNPC1 to the
ARE in A2 probe, the RNA-binding activity of HuR
cannot be enhanced even if HuR and RNPC1 form a
heterodimer (Figure 5K). Nevertheless, it is still not
Figure 6. RNPC1 enhances the RNA-binding activity of HuR in vivo.( A) RKO cells were uninduced or induced to express HA-tagged RNPC1a for
16h, and then used for immunoprecipitation with anti-HA to capture RNPC1–RNA complexes, anti-HuR to capture HuR–RNA complexes, or
mouse IgG as a control. Total RNAs were puriﬁed from immunocomplexes and subjected to RT–PCR to measure the level of p21 transcript
associated with RNPC1a or HuR. The level of GAPDH was also measured as a control. (B) The level of p21 transcript associated with RNPC1- or
HuR-immunocomplexes was quantiﬁed by qRT–PCR. *P<0.01 (Students’ t-test). (C) The level of RNPC1a was measured by RT–PCR in MCF7
cells uninduced ( ) or induced (+) to knock down RNPC1a for 3days. (D) MCF7 cells were uninduced or induced to knockdown RNPC1a for 3
days, and then used for immunoprecipitation with anti-HuR to capture HuR–RNA complexes or mouse IgG as a control. Total RNAs were puriﬁed
from immunocomplexes and subjected to RT–PCR to measure the level of p21 transcript associated with HuR. The level of GAPDH was also
measured as a control.
Figure 7. Regulation of p21 by an integrated network of the p53
pathway.
Nucleic Acids Research,2010, Vol.38, No. 7 2265clear why the interaction of RNPC1 with HuR does not
enhance the RNA-binding activity of RNPC1, which
merits further investigation.
HuR is a ubiquitously expressed member of the
Hu/ELAV family and primarily localized in nucleus at a
normal condition (22). However, in response to a stress
signal, such as UV irradiation, HuR is translocated from
nucleus to cytosol wherein HuR binds to its target RNAs
and then regulates their stability or translation (34).
Not surprisingly, the translocation of HuR from nucleus
to cytosol is tightly controlled. This includes: enhanced
cytoplasmic translocation of HuR via methylation at
residue R217 by CARM1 and phosphorylation at
residue S221 by PKC; and nuclear retention of HuR via
phosphorylation at residue S202 by CDK1 and at residue
S242 by an unknown kinase (22). Here, we showed that
HuR activity is modulated by RNPC1 via protein–protein
interaction. Given the fact that in response to stress
signals, RNPC1 expression is induced and HuR is
activated through translocation, the enhanced RNA-
binding activity of HuR by RNPC1 represents a
coordinated eﬀort to regulate key DNA damage respon-
sive genes, such as p21, under a stress condition.
RRM domain is known to serve as a domain for
protein–protein interaction as well as a domain for
RNA binding (31). Here, we provided evidence that
RNPC1 directly interacts with HuR via the RRM
domain in RNPC1 and RRM3 in HuR. In addition, we
found that the C-terminal unique region in RNPC1a con-
tributes to its interaction with HuR since RNPC1b, which
lacks most of the C-terminal region, is weak in interacting
with HuR (Figure 3C). Consistent with this, the extent of
enhanced HuR RNA-binding activity is stronger by
RNPC1a than that by RNPC1b (Figure 5G–H). These
data further support our hypothesis that upon interaction
with HuR, the binding of RNPC1 to the upstream AREs
stabilizes the binding of HuR to the downstream AREs in
p21 30-UTR.
Our hypothesis for how RNPC1 and HuR coordinately
regulate p21 mRNA stability may explain similar phe-
nomenon for the regulation of HIF-1a by HuR and
RNA-binding protein PTB. Both HuR and PTB are
known to promote translation of HIF-1a (35), but the
mechanism is still uncertain. It is possible that HuR and
PTB may enhance each other’s RNA-binding aﬃnity to
HIF-1a mRNA and thus cooperatively upregulate HIF-1a
translation. Similarly, if RNPC1 were found to bind
HIF-1a transcript, it is possible that RNPC1 may
enhance the RNA-binding activity of HuR to HIF-1a
and thus cooperatively regulate HIF-1a translation.
Finally, we would also like to note that the extent of the
increased level of p21 mRNA is less than that of p21
protein (Figure 1), suggesting that other mechanism may
be involved in p21 expression, especially protein transla-
tion. Since RNA-binding protein is known to regulate
protein translation and p21 is subject to translational
control (36), we examined the possibility that RNPC1
may regulate p21 translation. Indeed, we found that in
the presence of RNPC1, the extent of p21 mRNA
associated with polysomes is increased (data not shown).
Furthermore, we found that the level of newly synthesized
p21 protein is increased in the presence of RNPC1 (data
not shown). Considering that p21 translational regulation
by RNPC1 possibly together with HuR has a signiﬁcant
implication in the cell-cycle control, further study is war-
ranted to address this issue.
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